InvestorsHub Logo
Followers 0
Posts 5
Boards Moderated 0
Alias Born 02/06/2012

Re: None

Friday, 08/03/2012 5:46:51 PM

Friday, August 03, 2012 5:46:51 PM

Post# of 6149
Pfizer's maraviroc in "cure for HIV" drug category.

Top scientists say a "CCR5 antagonist," if not maraviroc, then a next-generation version of it, could be part of the long-awaited cure for HIV.

Some background:

Mutations in human genes cause muscular dystrophy, but a mutation in the CCR5 gene has a huge health benefit: people with it are almost completely resistant to HIV infection. Since that discovery was made in 1996, Pfizer and other companies have become focused on developing a treatment that mimics the effects of a CCR5 mutation.

Here is a summary I wrote describing CCR5 antagonists and the race for a cure for HIV: http://bit.ly/OGbWQn

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PFE News